What is Solarea Bio worth?
$37.0Mlast known valuation
Solarea Bio last raised $9.9M in its Early Stage VC (Nov 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Solarea Bio
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Early Stage VC | $9.9M | ▮ | ▮ |
| Aug 2024 | Seed Round | $1.0M | ▮ | ▮ |
| May 2023 | Later Stage VC (Series B) | $15.0M | ▮ | ▮ |
| Sep 2020 | Early Stage VC (Series A) | $11.3M | ▮ | ▮ |
How Solarea Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Solarea Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Solarea Bio worth?
- Solarea Bio's last known valuation is $37.0M.
- How much has Solarea Bio raised?
- Solarea Bio has raised $37.4M in total funding across 4 recorded rounds.
- When did Solarea Bio last raise?
- Solarea Bio last raised in Nov 2025 (Early Stage VC), raising $9.9M.